Several hot topics on treatment of gallbladder cancer

doi:10.16139/j.1007-9610.2019.02.003

[1] Zaidi MY, Maithel SK.Updates on gallbladder cancer management[J]. Curr Oncol Rep,2018,20(2):21.
[2] Ethun CG, Postlewait LM, Le N, et al.Association of optimal time interval to re-resection for incidental gallbladder cancer with overall survival: a multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium[J]. JAMA Surg,2017,152(2):143-149.
[3] Addeo P, Centonze L, Locicero A, et al.Incidental gallbladder carcinoma discovered after laparoscopic cholecystectomy: identifying patients who will benefit from reoperation[J]. J Gastrointest Surg,2018,22(4):606-614.
[4] Creasy JM, Goldman DA, Gonen M, et al.Predicting residual disease in incidental gallbladder cancer: risk stratification for modified treatment strategies[J]. J Gastrointest Surg,2017,21(8):1254-1261.
[5] 田远虎. 腹腔镜胆囊切除术术中或术后发现意外胆囊癌的外科治疗[J]. 中华外科杂志,2015,53(2):135-139.
[6] Duffy A, Capanu M, Abou-Alfa GK, et al.Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre(MSKCC)[J]. J Surg Oncol,2008, 98(7):485-489.
[7] Du J, Yang XW, Wen ZJ, et al.Relationship between prognosis and time interval from cholecystectomy to reo-peration in postoperative incidental gallbladder carcinoma[J]. Chin Med J (Engl),2018,131(20):2503-2505.
[8] Lee H, Kwon W, Han Y, et al.Optimal extent of surgery for early gallbladder cancer with regard to long-term survival: a meta-analysis[J]. J Hepatobiliary Pancreat Sci,2018,25(2):131-141.
[9] 段安琪, 邱应和, 易滨, 等. 意外胆囊癌在腹腔镜切除术中或术后的处理对策[J]. 临床和实验医学杂志,2016,15(1):62-64.
[10] Goetze TO, Paolucci V.The prognostic impact of positive lymph nodes in stages T1 to T3 incidental gallbladder carcinoma: results of the German Registry[J]. Surg Endosc,2012,26(5):1382-1389.
[11] Sternby Eilard M, Lundgren L, Cahlin C, et al.Surgical treatment for gallbladder cancer - a systematic literature review[J]. Scand J Gastroenterol,2017,52(5):505-514.
[12] 孙静锋, 赵何伟, 郑苏文, 等. 根治性切除及单纯胆囊切除对Ⅱ期胆囊癌疗效的Meta分析[J]. 中国肿瘤外科杂志,2013,5(1):33-36.
[13] Ito H, Ito K, D'Angelica M, et al. Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment[J]. Ann Surg,2011,254(2):320-325.
[14] 程石. 重视意外胆囊癌再次手术的规范[J]. 临床外科杂志,2017,25(6):423-425.
[15] Shindoh J, de Aretxabala X, Aloia TA, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer an international multicenter study[J]. Ann Surg,2015,261(4):733-739.
[16] Vinuela E, Vega EA, Yamashita S, et al.Incidental gallbladder cancer: residual cancer discovered at oncologic extended resection determines outcome: a report from high- and low-incidence countries[J]. Ann Surg Oncol,2017,24(8):2334-2343.
[17] 中华医学会外科学分会胆道外科学组. 胆囊癌诊断和治疗指南(2015版)[J]. 中华消化外科杂志,2016,14(3):411-419.
[18] Piccolo G, Piozzi GN.Laparoscopic radical cholecystectomy for primary or incidental early gallbladder cancer: the new rules governing the treatment of gallbladder cancer[J]. Gastroenterol Res Pract,2017,2017:8570502.
[19] Berger-Richardson D, Chesney TR, Englesakis M, et al.Trends in port-site metastasis after laparoscopic resection of incidental gallbladder cancer: A systematic review[J]. Surgery,2017,161(3):618-627.
[20] Maker AV, Butte JM, Oxenberg J, et al.Is port site resection necessary in the surgical management of gallbladder cancer?[J]. Ann Surg Oncol,2012,19(2):409-417.
[21] Ethun CG, Postlewait LM, Le N, et al.Routine port-site excision in incidentally discovered gallbladder cancer is not associated with improved survival: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium[J]. J Surg Oncol,2017,115(7):805-811.
[22] 汤朝晖, 田孝东, 魏妙艳, 等. 美国癌症联合委员会胆道恶性肿瘤分期系统(第8版)更新解读[J]. 中国实用外科杂志,2017,37(3):248-254.
[23] Lee W, Jeong CY, Jang JY, et al.Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study[J]. Surgery,2017,162(3):515-524.
[24] 汤朝晖, 刘颖斌, 全志伟. 肿瘤分期对胆囊癌术式选择及预后判断临床意义研究[J]. 中国实用外科杂志,2011,31(3):224-227.
[25] Smith-Cohn MA, Gill D, Voorhies BN, et al.Case report: pembrolizumab- induced type 1 diabetes in a patient with metastatic cholangiocarcinoma[J]. Immunotherapy,2017,9(10):797-804.
[26] Czink E, Kloor M, Goeppert B, et al.Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer[J]. Cold Spring Harb Mol Case Stud,2017,3(5):a001974.
[27] 陈亚进, 陈贤清. 程序性细胞死亡蛋白-1及其配体抑制剂在胆道肿瘤治疗中的现状与前景[J]. 中华消化外科杂志,2018(3):219-224.

Several hot topics on treatment of gallbladder cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	ZHANG Hongzhan, ZHANG Kai. Current status and prospect of endoscopic photodynamic therapy for unresectable extrahepatic cholangiocarcinoma and ampullary carcinoma [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 316-320.
[2]	ZHU Siwei, YIN Xinmin. Laparoscopic radical resection of hilar cholangiocarcinoma: current status and considerations [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 100-103.
[3]	LI Xiangcheng, CHEN Yananlan, LI Changxian. Vascular reconstruction in radical resection for hilar cholangiocarcinoma [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 104-109.
[4]	XING Ying, CHENG Shi. Neoadjuvant therapy for gallbladder cancer: current status and challenge [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 110-114.
[5]	LUO Fangxiu, MA Qianchen, YUAN Fei. The fifth edition of WHO classification of digestive system tumors: update and progress on biliary system tumors [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 124-131.
[6]	WANG Yuanjiang, ZOU Hao. Clinical study on comprehensive treatment of gallbladder cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 171-176.
[7]	CHEN Xuanwu, YANG Chuanyu, JIANG Minjie, DU Weidong. Progress of study on gallbladder adenomyomatosis: pathogenesis, diagnosis and treatment [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 87-90.
[8]	WANG Kaiyu, WANG Liang, SHU Bin, ZHANG Yuewei, HUANG Xin, GE Xiaqing, XIAO Ming, ZHANG Qijia, YAN Zhe, SONG Yan, XIANG Canhong. Radical resection of hilar cholangiocarcinoma combined with left hepatectomy and resection of ventral segment of right anterior sector: one case report [J]. Journal of Surgery Concepts & Practice, 2021, 26(05): 441-444.
[9]	WU Wenta, LI Wei, CAO Yijun. Diagnosis and treatment of xanthogranulomatous cholecystitis [J]. Journal of Surgery Concepts & Practice, 2021, 26(03): 271-274.
[10]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 107-110.
[11]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 115-119.
[12]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 120-123.
[13]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 124-129.
[14]	LIU Hongzhi, LIN Ziguo, HUANG Jianlong, ZHOU Weiping, CHENG Zhangjun, LOU Jianying, ZHENG Shuguo, BI Xinyu, WANG Jianming, GUO Wei, LI Fuyu, WANG Jian, ZHENG Yamin, LI Jingdong, CHENG Shi, LIU Jingfeng, ZENG Yongyi. Effect of surgical margin width on prognosis in patients with single intrahepatic cholangiocarcinoma from a multicenter study [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 130-137.
[15]	SI Anfeng, LEI Zhengqing, YANG Pinghua, JIANG Tao, WANG Xuan, CHENG Zhangjun. Effectiveness of postoperative transarterial chemoembolization for huge intrahepatic cholangiocarcinoma [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 138-143.